πŸ•΅οΈ Immunome Inc. ($IMNM)

SEC insider & ownership activity, last 12 months Β· CIK 1472012 Β· every row links its SEC filing

Over the last 12 months insiders sold $27.5M against $2.3M of open-market buying. Barchas Isaac sold $18.3M through a 10b5-1 trading plan in 12 lots (Dec–Aug). No red-flag 8-Ks in the window.

Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net -$6.9M Jan 2026: net +$0 Feb 2026: net +$0 Mar 2026: net -$791K Apr 2026: net -$1.6M May 2026: net +$104K Jun 2026: net -$4.3M Jul 2026: net -$5.9M Aug 2026: net -$5.4M Sep 2026: net -$334K
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

3 buyers, $2.3M (11 lots) Β· 7 sellers, $27.5M (28 lots)

InsiderBuysBoughtSellsSoldLast
Barchas Isaac0– 12$18.3MAug 12, 2026
Rosett Max0– 3$2.5MJun 15, 2026
Lechleider Robert0– 5$2.3MJul 2, 2026
Horn Kinney0– 2$2.3MAug 4, 2026
Clay B. Siegall4$1.7M 0–Mar 27, 2026
Wagenheim Philip0– 2$1.3MMar 23, 2026
Bienaime Jean Jacques6$351K 2$204KJun 5, 2026
Higgins Jack0– 2$538KSep 11, 2026
Tsai Philip1$205K 0–Dec 19, 2025

5%+ holders

HolderStakeClassScheduleEvent
T. ROWE Price Investment Management, Inc. 17.4% 13GAug 14, 2026 filing β†—
FMR LLC 15.0% 13GOct 7, 2025 filing β†—
Abigail P. Johnson 15.0% 13GOct 7, 2025 filing β†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Higgins Jack$334KSep 11, 2026 filing β†—
Barchas Isaac$301KAug 12, 2026 filing β†—
Abhmc II, LLC$2.8MAug 6, 2026 filing β†—
Horn Kinney$2.3MAug 4, 2026 filing β†—
Horn Kinney$27KJul 7, 2026 filing β†—
Abhmc II, LLC$2.4MJul 6, 2026 filing β†—
Lechleider Robert$1.2MJul 2, 2026 filing β†—
Abhmc II, LLC$2.1MJul 2, 2026 filing β†—
Abhmc II, LLC$2.1MJun 30, 2026 filing β†—
Arsenal Bridge Venture II-B, LLC$22KJun 30, 2026 filing β†—
Lechleider Robert$1.1MJun 25, 2026 filing β†—
Rosett Max$1.1MJun 15, 2026 filing β†—
Rosett Max$1.4MApr 2, 2026 filing β†—
Higgins Jack$204KApr 2, 2026 filing β†—
Wagenheim Philip$1.4MMar 20, 2026 filing β†—

Material events (8-K)

ItemEvent date
Earnings (2.02)Aug 11, 2026 filing β†—
Financial Statements and Exhibits (9.01)Aug 11, 2026 filing β†—
Shareholder vote (5.07)Jun 9, 2026 filing β†—
Earnings (2.02)May 12, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 12, 2026 filing β†—
Earnings (2.02)Mar 3, 2026 filing β†—
Financial Statements and Exhibits (9.01)Mar 3, 2026 filing β†—
Other events (8.01)Dec 16, 2025 filing β†—
Financial Statements and Exhibits (9.01)Dec 16, 2025 filing β†—
Reg FD disclosure (7.01)Dec 15, 2025 filing β†—
Other events (8.01)Dec 15, 2025 filing β†—
Financial Statements and Exhibits (9.01)Dec 15, 2025 filing β†—
Earnings (2.02)Nov 6, 2025 filing β†—
Financial Statements and Exhibits (9.01)Nov 6, 2025 filing β†—